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Background: Although usage and acceptance are important factors for a successful implementation of clinical
decision support systems for medication, most studies only concentrate on their design and outcome. Our
objective was to comparatively investigate a set of traditional medication safety measures such as medication safety
training for physicians, paper-based posters and checklists concerning potential medication problems versus the
additional benefit of a computer-assisted medication check. We concentrated on usage, acceptance and suitability
of such interventions in a busy emergency department (ED) of a 749 bed acute tertiary care hospital.
Methods: A retrospective, qualitative evaluation study was conducted using a field observation and a
questionnaire-based survey. Six physicians were observed while treating 20 patient cases; the questionnaire, based
on the Technology Acceptance Model 2 (TAM2), has been answered by nine ED physicians.
Results: During field observations, we did not observe direct use of any of the implemented interventions for
medication safety (paper-based and electronic). Questionnaire results indicated that the electronic medication
safety check was the most frequently used intervention, followed by checklist and posters. However, despite their
positive attitude, physicians most often stated that they use the interventions in only up to ten percent for
subjectively “critical” orders. Main reasons behind the low usage were deficits in ease-of-use and fit to the workflow.
The intention to use the interventions was rather high after overcoming these barriers.
Conclusions: Methodologically, the study contributes to Technology Acceptance Model (TAM) research in an ED
setting and confirms TAM2 as a helpful diagnostic tool in identifying barriers for a successful implementation of
medication safety interventions. In our case, identified barriers explaining the low utilization of the implemented
medication safety interventions - despite their positive reception - include deficits in accessibility, briefing for the
physicians about the interventions, ease-of-use and compatibility to the working environment.
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Medication errors and adverse drug reactions (ADRs) are
one of the most frequent causes of death in many coun-
tries [1-3]. In Germany, between 17.000 and 58.000 deaths
per year may be caused by medication errors [4,5]. Up to
50 percent of these cases are judged to be preventable.
Prevention strategies include medication safety guidelines,
improved training and awareness of staff as well as com-
puterized clinical decision support systems (CDSS). Such
strategies promise to reduce medication errors and ad-
verse drug events [6-9], but without guaranteeing success.
Improved pharmacotherapy implies that clinicians apply
those tools and utilities on a regular basis. Several studies
demonstrated that computerized CDSS were not success-
ful due to limited or no system use [10-14]. The launch of
such systems requires an adequate awareness and the de-
termination to alter existing medication procedures, thus
making user acceptance a key factor for successful imple-
mentation [15]. Several methods and models have been
published to examine factors which influence the ac-
ceptance of innovations. Examples include the Theory
of Reasoned Action (TRA) [16,17], the Theory of Planned
Behavior (TPB) [18], the Task-Technology Fit Model
[19,20], the Diffusion of Innovation (DOI) Theory [21] or
the Technology Acceptance Model (TAM) [22] with its
extensions TAM2 [23], TAM3 [24] and the Unified
Theory of Acceptance and Use of Technology (UTAUT)
[25]. In the clinical context TAM (respectively its exten-
sions) is used increasingly [26,27]. While TAM postulates
that perceived usefulness and perceived ease-of-use are the
key factors in the adoption, its further development TAM2
posits subjective norm, image, job relevance, output quality
and result demonstrability as additional antecedents to the
perceived usefulness variable. TAM3 advanced TAM2 with
six additional antecedents for the perceived ease-of-use
variable, which are computer self-efficacy, perceptions of
external control, computer anxiety, computer playfulness,
perceived enjoyment and objective usability. The UTAUT
has integrated different technology acceptance models
including TAM and contains performance expectancy
(equivalent to perceived usefulness in TAM), effort expect-
ancy (equivalent to perceived ease-of-use in TAM), social
influence and facilitating conditions as core predictors.
In a research project supported by the German Federal
Ministry of Health, drug associated risk situations are
analyzed among patients visiting the emergency depart-
ment (ED) of a tertiary care acute hospital in Germany
[28,29]. Interventions included different paper- and
computer-based medication safety measures, which were
implemented in the ED. The primary aim of this re-
search was:
1. to examine whether and to what extend the different
interventions were used2. to assess the acceptance and suitability of the
different medication safety interventions for the ED
based on the acceptance model TAM2 and
3. to detect reasons for adoption or rejection of
interventions and to derive recommendations for
enhancing acceptance and use of interventions.
Methods
Study design and setting
A retrospective, qualitative study was conducted following
the introduction of a series of interventions to improve
medication safety. In a first step a field observation was
carried out. In a second step a questionnaire, based on the
TAM2 framework [23], was deployed to assess use and ac-
ceptance of the different medication safety interventions.
The study was conducted at the ED of Klinikum
Fuerth, Germany, a tertiary care hospital with 749 beds
and an annual ED census of 45.000 patients. During the
time of the interventions the ED team comprised one
consultant, three senior physicians, two specialists in
internal medicine and six junior doctors. In 2011 a set of
paper-based and computer-based interventions have
been implemented consecutively in the ED to improve
medication safety within a grant project from the
“German Coalition for Patient Safety” (BMG grant II
A 5–2509 ATS 003) [30].
The ethics board of the Friedrich-Alexander-University
of Erlangen-Nuremberg, Germany reviewed and approved
the study protocol. The Fuerth data safety commissioner
reviewed the technical infrastructure, data handling and
pseudonymization procedures. The Fuerth staff council
approved the participation of the employees.
The interventions to improve medication safety
All medication safety interventions were implemented
previous to this study. Paper-based interventions in-
cluded repeated training, posters concerning typical
medication safety problems and a pocket checklist listing
critical drugs and symptoms. Electronic interventions
resulted in a CDSS application [31] integrated with the
hospital’s electronic health record (EHR) system [32].
Repeated training
Along with physicians’ Monday rounds, additional regu-
lar medication safety training sessions were implemented
to increase physicians’ awareness of medication hazards
such as critical drug-drug interactions (DDIs), medica-
tion errors (MEs) and recent safety warnings of the drug
agency and regulatory authorities. Physicians practiced
the basic strategies for the recognition and prevention of
adverse drug events and were trained to use available
public domain drug information systems in the Internet.
Furthermore periodical quality circles with case review
were carried out.
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To support physicians, information posters and check-
lists were developed comprising lists of potentially in-
appropriate medications in order to quickly identify
patients of high risk. Lists for posters and checklists
were conceptually similar and included critical drugs,
typical drug associated symptoms, potential alternative
drugs and supportive procedures. The posters were
displayed prominently in the ED main room. The check-
lists were intended for physicians’ white coat pocket and
were distributed to all physicians working in the ED.
Computerized decision support
Initially neither computerized drug order entry (cPOE)
nor electronic CDSS were established in the ED. Prior to
this evaluation study, in 2011, the commercial EHR sys-
tem of the hospital [32] was modified and an electronic
ED case sheet was implemented to enable cPOE. In
addition, a commercially available CDSS for medication
safety checks [31] with an embedded drug information
system (DIS) [33] was integrated into the EHR system. As
a first measure, an electronic infobutton was implemented
to show brief information regarding critical contraindica-
tions and DDIs similar to the paper-based checklist. Add-
itional electronic measures included one checkbox for
each drug to prompt the physician if the drug had a valid
indication based on the patient status, one checkbox for
the patient case sheet itself to prompt the physician if an
adverse drug event (ADE) was likely and finally a
“MediCheck” button to send patient data to the commer-
cial CDSS and DIS for a comprehensive workup [34]. The
new electronic case sheet with these medication safety
functions was made available at all five work stations in
ED (three stationary PCs located in the resuscitation room
and two computers on wheels). The use of electronic
documentation was not mandatory; the previously existing
paper-based case sheet could be used alternatively.
The field observation
Targeted participants of the observation were physicians
working permanently or temporarily in shifts in the ED.
The sample size was determined by the selected obser-
vation dates. Six observations took place in the main re-
suscitation room in April and May 2012 (three in the
morning, three in the afternoon), over a period of five
weeks. Each visit lasted approximately two hours, physi-
cians were observed by a trained observer.
Observational results were recorded in semi-structured
pseudonymized notes, containing the job status of the ob-
served physician, the type of case sheet used (paper or
electronic form), the number of (critical) drugs entered in
the electronic case sheet and which measures (poster,
checklist and/or digital case sheet) were applied. For the
electronic interventions the type of computer-assistedcheck (infobutton, checkbox “indication for drug known”,
checkbox “adverse drug event”, “MediCheck”-button) was
recorded. In addition, environmental specifics, e.g. system
failures, lack of accessibility or work interruptions were
documented. System logs were used to cross-check the
observation results and to generate usage statistics for the
observation days. During analysis, the data has been com-
pletely anonymized. Observation results were summarized
in tabular format using a thematic coding frame and the
results have been analyzed descriptively.
The TAM2 based questionnaire
Following the field observation a paper-based question-
naire was distributed to the 12 physicians belonging to
the permanent ED staff in May 2012 during a regular
physician meeting and recollected at the end of the
meeting. Participation was voluntarily and anonymity
was guaranteed. The questionnaire instrument had three
partitions:
 Part A examined the use of the different medication
safety interventions and included open ended
questions to determine reasons for restricted use.
 Part B was based on the TAM2 research model and
comprised questions on physicians’ acceptance as
well as the rated suitability of the measures used.
 Part C concerned basic demographic data such as
job status, working experience and computer skills.
The complete questionnaire is available as Additional file
1. The questionnaires were analyzed descriptively for fre-
quency, means, and standard deviations. For all statistic
evaluations cases with missing values were listwise deleted.
Exact Wilcoxon signed-rank test was used to compare ac-
ceptance data between paper-based and electronic-based
measures. Pearson correlation coefficients were deter-
mined for relations between acceptance variables. In order
to account for small sample sizes Monte Carlo approxima-
tions with 10.000 samples were applied for significance
testing. Friedman test was applied for testing differ-
ences between measures’ suitability rankings. All sta-
tistics were performed at a 5 percent significance level.
All calculations were conducted via SPSS 20.0.
The TAM2 research model applied in part B has been
used previously in the medical field (e.g. [35-38]). TAM2
can be used to determine reasons why a new technology
is adopted or declined. In our case, TAM2 was applied
as well for paper-based interventions and for comput-
erized interventions. According to TAM2, user accept-
ance - measured by the intention to use a technology - is
depending on perceived ease-of-use and perceived useful-
ness. “Perceived ease-of-use” (PEOU) refers to the degree
a person believes that using the technology requires effort.
“Perceived usefulness” (PU) is defined as the degree a
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formance. Then, there are three cognitive factors (job rele-
vance, output quality, result demonstrability) and three
social factors (subjective norm, image, voluntariness)
which influence usage intention (ITU) indirectly. Among
those, “Job relevance” (JR) is defined as individual’s per-
ception of the degree to which technology is relevant for
his/her job. “Output quality” (OQ) is defined as individ-
ual’s perception of how well a technology performs tasks
necessary in his/her job. “Result demonstrability” (RD)
describes tangibility of results using the technology. “Sub-
jective norm” (SN) is the degree to which an individual
perceives that important others believe he/she should
(not) use the technology. “Image” (IM) is defined as the
degree to which one perceives the use of the technology as
means to enhance the own social status. “Voluntariness”
(VO) describes if the decision to adopt the technology is
self-determined. In addition, the relationship between
“perceived ease-of-use” (PEOU) and “usage intention”
(ITU) is moderated by the factor “experience” (EXP),
whereas TAM2 postulates that with increasing experi-
ence the effect of PEOU and ITU will decrease.
Although TAM2 is an established model, it needed ex-
tension with further constructs to capture the unique con-
textual features and to enhance its explanation capabilities
for the ED medication safety field. Based on the previous
field observation and suggestions from literature [39,40]
TAM2 was extended with the variables “compatibility” (to
workflow) defined as “the degree to which an innovation
is perceived being consistent with the existing values,
needs, and past experiences” [40] and “resistance to
change”, described as “any conduct that serves to maintain
the status quo in the face of pressure to alter the status
quo” [39]. The extended TAM2 used here to explain the
adoption or rejection of implemented medication safety
interventions is presented in Figure 1.
The TAM2 scales were operationalized using validated
items from previous research. Items for “perceived use-
fulness” (PU), “perceived ease-of-use” (PEOU), “subject-
ive norm” (SN), “image” (IM), “job relevance” (JR),
“output quality” (OQ), “result demonstrability” (RD) and
“intention to use” (ITU) were taken from the validated
questionnaire of Chismar and Wiley-Patton [35]. This
questionnaire was developed for future internet-based
health care applications in a pediatric community and
needed adaptations such as translation into German lan-
guage, changes in wording (“Internet-based applications”
was replaced with “medication safety measures”; “pediatric
care” was replaced with “patient care”) and changes of
future tense to present tense in the items. The additional
items to examine physicians’ “resistance to change” (RTC),
“compatibility” (COM) to work practice and “voluntari-
ness of use” (VO) have been added from Bhattacherjee
and Hikmet [39], Moore and Benbasat [40] and Venkateshand Davis [23]. Response to all TAM2 items was mea-
sured on a five-point Likert scale ranging from 1 =
strongly disagree to 5 = strongly agree. To avoid enforced
decisions and distortion of the results the option “not
applicable” was available.
The modified questionnaire was reviewed by two ex-
perts in the field of health IT evaluation and one medical
expert in the field of acute care. In addition, the second
part of the questionnaire was piloted with nine employees
of the University Medical Centre Erlangen-Nuremberg.
Based on participants’ feedback, wording was slightly
modified and four items were removed. The resulting
Cronbach’s Alpha values (ranging from 0.86 to 1.00) indi-
cated a satisfactory reliability level. The final TAM2 part
included 26 items (see Table 1).
Results
Field observation results
From April to May 2012 six observations were conducted
and 20 cases involving a total of six physicians were ob-
served. ED physicians of permanent staff were observed in
60% (12/20) of the cases and physicians working tempor-
arily at the ED in 40% (8/20) of the cases.
In 90% (18/20) of the observed cases the electronic
case sheet was used for documenting, but only in 22%
(4/18) of these cases detailed drug information for each
drug was entered into the electronic case sheet. In none
of the cases utilization of the paper-based interventions
(pocket checklist or poster) could be observed. When-
ever drugs were associated with an infobutton indicating
that this drug was involved in a drug risk situation, this
was ignored in all cases and the button was not invoked.
Furthermore, no utilization of the checkbox “indication
for drug known” could be observed. In none of the ob-
served cases the physicians selected the comprehensive
“MediCheck” CDSS and DIS call (Table 2).
A specific cross-check of the electronic case sheets for all
six observation days identified that within the six times
24 hours 62% of the electronic case sheets (126/204) were
without recorded drugs. 17.5% of these cases (22/126) re-
ceived de facto no drugs. But in 65% (82/126) the checkbox
“medication according to annex” (a choice on the digital
case sheet) was selected instead of entering the drugs into
the system. Thus, in the majority of cases patients’ medica-
tion was only recorded in the paper case sheet or the paper
medication list obtained from the family physician or nurs-
ing home was simply attached to the paper case sheet. In
those cases the corresponding drug indications or contrain-
dications could not be checked electronically.
Questionnaire results
Subject characteristics (part C)
Ten responses were obtained from a total of 12 physi-
cians. A first analysis of the responses showed that one
Figure 1 Adapted TAM2 model.
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naire and therefore was excluded from later analysis.
Nine valid questionnaires with an absolute response rate
of 75 percent were included. Among them there were
two senior physicians, one specialist in internal medicine
and six junior physicians. Age and gender have not been
asked. About two-thirds (6/9) of the respondents had
less than five years medical experience. Half of the par-
ticipants (5/9) reported “less than 3 years” experience
with electronic medical records; the majority (7/9)
judged their computer experience “medium”. Seven phy-
sicians had used the paper-based interventions in the
past, eight physicians had used the computer applica-
tions in the past and one physician had no experiences
with either intervention.
Self-reported use of the interventions (part A)
44.4% (4/9) of the participants preferred the usage of the
electronic interventions over paper-based checklist
(11.1%, 1/9) and posters (0/9), while looking for infor-
mation about contraindications and drug-drug interac-
tions (item U1). In addition, two physicians used the
“Arzneimittel pocket” (popular German pocket drug ref-
erence), one respondent indicated relying on the Inter-
net and one physician mentioned asking colleagues.
We included two items for assessing utilization of
medication safety interventions. Table 3 illustrates the
results of the first item “frequency of use” (item U3),
which was measured on a five-point scale ranging from
“don’t use it at all” to “several times a day”. We summa-
rized “once a day” and “several times a day” under thecategory “daily”. As results show, the electronic medica-
tion safety check (8 users) was reportedly the most fre-
quently used intervention compared to the paper-based
checklist (6 users) and poster (4 users). More than half
of the participants (5/9) reported daily use of the elec-
tronic interventions; one third (3/9) indicated weekly
use. Narrative comments (item U7) indicated that the
check is mostly applied (a) during patient admission, (b)
when reading the case sheet, (c) before ordering drugs
for checking dosage, (d) before transferring patients to an-
other ward and (e) in all situations of polypharmacy. In
detail (item U6), the infobutton was the most widely uti-
lized electronic function (8/8 physicians), followed by the
“MediCheck” invoked DIS and CDSS (5/8 physicians
each). The checkbox “adverse drug event” was reportedly
used by half (4/8) of the physicians, the checkbox “indica-
tion for drug known” was used least (2/8 physicians).
The second item “In case of a critical drug order: To
what percentage do you use the measures?” (item U4)
was most frequently answered with “up to 10%” for all
types of paper-based and computerized interventions.
However, we identified two participants (number 4 and
8), who applied all interventions for “up to 50%” respect-
ively “up to 100%” of the critical orders (Table 4). Al-
most one quarter of the participants stated that they got
no briefing for the use of posters, checklists and elec-
tronic medication checks (item U2).
With item U8 we asked for reasons for the low utilization
previously identified in the field observation. There, the
participants named (a) time effort, (b) availability, (c) miss-
ing briefing for the interventions, (d) (missing) ease-of-use
Table 1 Summary of the measurement items
Items Measurement Cronbach’s α after
item deleted
Source
U1 If you have questions on interactions and contraindications of drugs: How do you inform yourself at first? (look at the poster/look at the
pocket- checklist/use the electronic medication check/ask colleagues/look at the “red list” (print version)/others -please specify)
– self- development
U2 Have you gotten a briefing regarding the usage of the measures? (yes/no)
U3 How often do you use the measures in your daily routine? (not at all/monthly/weekly/once a day/several times a day)
U4 In case of a critical drug order: To what percentage do you use the measures? (not at all/up to 10%/up to 25%/up to 50%/up to 100%)
U5 When have you used the measure for the last time? (never use/today/…days before)
U6 Which information sources do you usually use when checking medication electronically? (infobutton/checkbox “indication for drug
known”/OntoDrug/PharmIndex/checkbox “ADE”/use no source)
U7 In which situations do you use the computer-assisted medication check? (open- ended)
U8 Previous field observations indicated that measures have not been used often. What can be the reasons for low usage in your opinion?
(open-ended)
U9 What should be improved so that measures are used more frequently? (open-ended)
PU 0.882 PU1- self-
development; [35]
PU1 Medication safety measures basically make sense.
PU2 The measures could increase my productivity.
PU3 The measures could improve the quality of care.
PU4 The measures could enhance my effectiveness.
PU5 The measures could be useful in my job.
PEOU 0.949 [35]
PEOU1 My interaction with measures is clear and understandable.
PEOU2 The measures are easy to use.
PEOU3 Interacting with measures will not require a lot of mental effort.
PEOU4 It will be easy to get measures to do what I want them to do.
SN – [35]
SN1 Physicians who influence my behavior think I should use the measures.
IM 0.881 [35]
IM1 Having the measures is a status symbol.
IM2 Physicians who use the measures have more prestige than those who do not.
IM3 Physicians who use the measures have a high profile.
JR 0.869 [35]
JR1 Usage of the measures is relevant to the delivery of patient care.


























Table 1 Summary of the measurement items (Continued)
OQ1 The quality of drug information is high.
RD 0.860 [35]
RD1 The measures could reduce the costs of my care delivery.
RD2 I believe I can communicate to others the consequences of using the measures.
RD3 The results of using the measures are apparent to me.
RD4 I have difficulty explaining why using the measures may or may not beneficial.
COM – [40]
COM1 Using the measures fits well with the way I work.
RTC 0.860 [39]
RTC1 I don’t want the measures to change the way I order patient medication.
RTC2 Overall, I don’t want the measures to change the way I currently work.
VO – [23]
VO Use of the measures is voluntary.
ITU 1.000 [35]
ITU1 Assuming that significant barriers to the use are overcome, I intend to use the measures.
ITU2 If significant barriers did not exist, I predict I would use the measures.
General
Suitability
GLO1 How suitable do you judge the measures (training/poster/checklist/infobutton/checkbox “indication for drug known”/OntoDrug/
PharmIndex/checkbox “ADE”) for emergency department? (5-point rating scale ranging from 1 = least suitable to 5 = above all suitable)
– self- development
DG1 What is your professional status? (senior physician/specialist in internal medicine/junior doctor) – self- development
EXP1 How long have you been working as a physician? (for…years)
EXP2 How long have you been working with electronic patient records? (for…years)

























Table 2 Results of field observation on the use of the interventions
Case Status of the observed person Type of
case sheet






1 specialist in internal medicine ED digital annex 0 . none
2 specialist in internal medicine ED digital annex 0 . none
3 specialist in internal medicine ED digital annex 0 . none
4 specialist in internal medicine ED digital annex 0 . none
5 specialist in internal medicine ED digital annex 0 . none
6 junior doctor Med1/Med2 digital . 6 2 none
7 junior doctor Med1/Med2 digital annex 0 . none
8 junior doctor Med1/Med2 digital medication plan of family physician 8 3 none
9 junior doctor Med1/Med2 digital medication plan of family physician 8 5 none
10 junior doctor Med1/Med2 digital annex 0 . none
11 junior doctor Med1/Med2 digital . . . none
12 specialist in internal medicine ED digital . 2 0 none
13 specialist in internal medicine ED digital annex 0 . none
14 specialist in internal medicine ED digital annex 0 . none
15 junior doctor ED digital annex 0 . none
16 senior physician ED digital patients statements 0 . none
17 medical specialist Med1/Med2 paper . . . none
18 junior doctor ED digital patients statements . . none
19 medical specialist Med1/Med2 paper patients statements . . none
20 junior doctor ED digital . . . none
Notes: “.” = unobservable events.
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of the main reasons for not using posters was the
lack of availability at the point of care as they were
not visible from all treatment cubicles. For the checklists
physicians reported missing briefing and low awareness as
they were better accustomed to the popular “Arzneimittel
pocket” drug reference. Also, the checklist was considered
too specific by only providing a limited list of critical
drugs. The most important reason to omit the electronic
medication safety interventions was lack of time to record
all patients’ admission drugs manually in the system. Fur-
thermore, physicians indicated some usability problems
e.g. to document half tablets in the case sheet. Correspond-
ing to these answers, the participants suggested improvedTable 3 Frequency of use of the interventions in daily
routine
Response categories
Interventions No usage Monthly Weekly Daily No answer
Paper poster 4 1 1 2 1
Paper checklist 2 3 0 3 1
Digital case sheet 1 0 3 5 0
Number of physicians who agreed to the specific category.briefing, faster drug documentation and the need for more
time to adapt to the interventions in order to improve
utilization (item U9).
Acceptance of the interventions according to TAM2 (part B)
Data is based on answers of those physicians, who used
the medication safety interventions in the past: n = 8 for
the computer-based interventions (functionalities of the
digital case sheet), n = 7 for the paper-based interven-
tions training, paper-based posters and pocket checklist.
Table 5 presents the average ratings of the different
interventions for each construct. Although ratings for
paper-based interventions were mostly somewhat lower,
differences between computer and paper-based interven-
tions were not significant due to the small sample size
(exact Wilcoxon signed-rank test, p < 0.05).
Overall, the results showed a moderate acceptance of
the various measures. Most of the mean values were
around the midpoint of 3 (“partly agree”) or achieved a
rating of 4 (“rather agree”) for the paper-based respect-
ively information technology-based (IT) interventions.
The lowest rated factors were image (IM, paper: 2.83/IT:
3.07), compatibility to the work flow (COM, paper: 2.57/
IT: 3.50) and perceived ease-of-use (PEOU, paper: 3.36/
IT: 3.38). The highest rated factors were job relevance
Table 4 Frequency of use in situations of subjectively “critical” drug orders

















Usage in …% of
critical orders
1 n.a. n.a. n.a. n.a. n.a. n.a. yes weekly up to 10%
2 yes monthly up to 10% yes monthly up to 10% yes weekly up to 10%
3 no never – no never – yes weekly up to 25%
4 yes weekly up to 25% no several
times a day
up to 50% no several
times a day
up to 50%
5 yes once a day up to 10% yes several
times a day
up to 25% yes several
times a day
up to 25%
6 yes never – yes monthly never yes once a day up to 10%
7 yes never – yes monthly up to 10% yes once a day up to 50%
8 yes once a day up to 50% yes several
times a day
up to 100% yes several
times a day
up to 100%
9 no never – no never – no never –
Notes: „n.a.” = no answer.
Table 5 Mean scores of physicians’ perceptions of the paper-based (“paper”) and computer-based (“IT”) interventions
(five-point-scale: 1 = strongly disagree; 5 = strongly agree)
Physician
Construct 1 2 3 4 5 6 7 8 Mean SD
PUpaper 2.67 4.40 – 2.80 4.40 1.60 4.60 4.80 3.61 1.240
PUIT 2.67 5.00 4.20 4.80 5.00 4.40 4.60 4.80 4.43 0.767
PEOUpaper 2.00 3.00 – 4.50 3.75 2.00 4.75 3.50 3.36 1.098
PEOUIT 2.00 5.00 4.00 3.00 3.75 4.00 2.50 2.75 3.38 0.982
SNPaper . 3.00 – 5.00 5.00 . 4.00 1.00 3.60 1.673
SNIT . 4.00 5.00 5.00 5.00 . 4.00 1.00 4.00 1.549
IMpaper . 2.50 – 3.00 2.50 3.00 3.00 3.00 2.83 0.258
IMIT . 3.50 3.50 3.00 2.50 3.00 3.00 3.00 3.07 0.345
JRpaper 4.50 3.00 – 4.00 4.00 5.00 5.00 5.00 4.36 0.748
JRIT 4.50 5.00 4.00 4.00 4.00 5.00 5.00 5.00 4.56 0.496
OQpaper . 3.00 – 3.00 . 5.00 3.00 5.00 3.80 1.095
OQIT . 5.00 3.00 5.00 . 5.00 3.00 5.00 4.33 1.033
RDpaper 3.00 3.25 – 3.00 4.00 3.00 4.00 5.00 3.61 0.762
RDIT 3.00 4.50 3.50 4.25 4.00 5.00 4.00 5.00 4.16 0.694
COMpaper 2.00 2.00 – 2.00 4.00 1.00 4.00 3.00 2.57 1.134
COMIT 2.00 5.00 3.00 4.00 4.00 4.00 4.00 2.00 3.50 1.069
¬RTCpaper 4.00 4.50 – . 4.00 5.00 5.00 5.00 4.58 0.492
¬RTCIT 4.00 4.50 3.00 . 4.00 5.00 5.00 5.00 4.36 0.784
VOpaper 5.00 5.00 – 5.00 3.00 5.00 5.00 4.00 4.57 0.787
VOIT 5.00 5.00 4.00 5.00 3.00 5.00 5.00 2.00 4.25 1.165
ITUpaper 2.50 4.00 – 5.00 . 1.00 5.00 . 3.50 1.732
ITUIT 2.50 5.00 4.00 5.00 . 5.00 5.00 . 4.42 1.021
All values non-significant in the exact Wilcoxon signed-rank test. Meaning of abbreviations: PU, perceived usefulness; PEOU perceived ease-of-use; SN subjective
norm; IM image; JR job relevance; OQ output quality; RD result demonstrability; COM compatibility; RTC resistance to change; VO voluntariness; ITU intention
to use.
Notes: “¬RTC” = values of RTC were reverse coded; “.” = could not be calculated because of missing values; “–“= interventions were not used.
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paper: 4.57/IT: 4.25) and (no) resistance to change
(¬RTC, paper: 4.58/IT: 4.36).
Both, paper-based and IT-based interventions were
rated as useful (PU, paper: 3.61/IT: 4.43), important to
support the work (JR, paper: 4.36/IT: 4.56) and were
of good information quality (OQ, paper: 3.80/IT:
4.33). The results of the medication safety measures
were “tangible”, observable and communicable (RD,
paper: 3.61/IT: 4.16). The influence of colleagues on
the usage behavior was judged as moderate (SN,
paper: 3.60/IT: 4.00). The application of the measures
was assessed as own free will (VO, paper: 4.57/IT:
4.25). The perceived ease-of-use (PEOU, paper: 3.36/
IT: 3.38) was ranked as moderate. The respondents
did not confirm that the use of such measures will
improve one’s status (IM, paper: 2.83/IT: 3.07). Al-
though the application of the interventions did not fit
into their current workflow (COM, paper: 2.57/IT:
3.50), physicians were willing to adapt their way of
working (¬RTC, paper: 4.58/IT: 4.36). The intention
to use the measures was moderate for paper-based in-
terventions (ITU, paper: 3.50) and rather high for IT-
based interventions (ITU, IT: 4.42) if barriers would
be overcome.
Relationship between TAM2 variables
To examine the relationship between variables and to
determine whether “perceived usefulness” (PU) and “per-
ceived ease-of-use” (PEOU) are associated with the
“intention to use” (ITU) and self-reported usage a cor-
relation analysis was conducted. Due to the small sample
size and the use of the more rigid Monte Carlo testing for
small samples most of these relationship tests did not
deliver statistically significant values. We could however
demonstrate a strong positive correlation between PU
and ITU for computer-based interventions (r = 0.960,
p < 0.05). Thus, the more useful the system was per-
ceived the more likely the participants would use it.
The correlation between PEOU and ITU was moderately
positive (r = 0.520), but not significant. A strong positive
correlation was found between COM and ITU (r = 0.917,
p < 0.05), indicating that improved (perceived) workflow
compatibility of the interventions is related with a higher
intention to use. ¬RTC was also positively correlated with
ITU (r = 0.559), but non-significant. For paper-based
interventions PU, PEOU, COM and ¬RTC are all
positively correlated with ITU (PU – ITU, r = 0.757;
PEOU – ITU, r = 0.914, COM – ITU, r = 0.725, ¬RTC –
ITU, r = 0.075), although none of these correlations was
significant. For both, computer-based and paper-based
measures, self- reported use correlated moderately and in-
significantly with ITU (ITU – usageIT, r = 0.560; ITU –
usagePoster, r = 0.506; ITU – usageChecklist, r = 0.440).Perceived suitability of interventions for the emergency
department (Part B)
We asked the participants to assess the suitability of
each intervention for the ED environment (item GLO1).
There, the repeated medication safety training received
the highest rating among the conservative interventions
(5/7), followed by the paper-based checklist for physi-
cians’ pocket (4/7) and the paper based posters (3/7).
Among the computer-assisted interventions, the infobutton
and the “MediCheck” invoking CDSS and DIS were equally
rated suitable with seven of eight physicians each. The
checkbox “adverse drug event” (ADE) came second (6/8).
The checkbox “indication for drug known” was placed
last with three of eight cases (see Figure 2). Differences be-
tween these rankings, however, were non-significant in




Our evaluation methodology combined a field observa-
tion with a questionnaire-based survey. Field observation
is an established method for examining the use of new
technologies [41,42]. To determine reasons for (non)
acceptance of technology we developed a question-
naire using TAM2 as theoretical framework and extended
the model with the factors “resistance to change” and
“compatibility” to workflow based on a literature review.
Venkatesh and Davis [23], for example, reported that all
traditional TAM2 variables influence intention to use
(ITU) positively. In addition, studies indicated that “com-
patibility” (COM) has a positive and direct impact on
behavioral intention to use a system [43-45]. Furthermore,
Bhattacherjee and Hikmet [39] could show, that users’
“resistance to change” (RTC) is negatively related to their
intention to use and that RTC is an important key inhibi-
tor of system utilization. Based on these publications we
assumed (for RTC with reversed coding) positive relation-
ships between constructs.
Content validity of the TAM2 part of the question-
naire is based on the fact that all investigated factors
reflect the current literature on information technol-
ogy acceptance in the healthcare domain. Construct
validity of this part is based on the fact that only vali-
dated constructs of TAM2 [23] and validated scales of
previous research [39,40] have been used. We performed
a pre-test for the modified questionnaire with nine
employees of an independent unit in the University
Medical Centre and obtained a Cronbach’s alpha of
0.86 to 1.00 as an indicator for the internal reliability.
Nine participants is a comparatively small sample for
the pre-test considering the fact that Peleg at al. [46]
reported that for eight participants a calculation of
reliability was not possible.
Figure 2 Rated suitability of the interventions for the emergency department. Ranking of the interventions based on their relative
frequencies. Ratings for “strongly agree” and “agree” were summarized under the category “positive”. Ratings for “strongly disagree” and
“disagree” were summarized under the category “negative”.
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The objectives of this study were (1) to analyze the
utilization of different medication safety interventions in
a busy ED environment, (2) to assess acceptance of the
interventions and their suitability for the ED and (3) to
identify reasons for utilization or non-utilization with
the goal to derive recommendations for improvement.
Related to our first research question, during the field
observation of six times two hours, we did not observe
any real live utilization of the implemented medication
safety interventions. In comparison, self-reported fre-
quency of use was rather high at least for electronic in-
terventions (daily in five of nine cases) although
physicians most often stated that they use the measures
only in ten percent of the subjectively critical orders.
This seems low; nevertheless there were some physicians
who indicated using the interventions regularly. Thus,
frequency of usage may depend on the physician. Work
experience and expert knowledge could be determining
factors where experienced physicians may not have the
need to check every prescription. Due to small sample
size we are not able to confirm or deny such an assump-
tion. According to self-reported data computer-based in-
terventions have been used more often than paper-based
interventions. The infobutton producing a tooltip with
short information of general interactions and contra-
indications for the respective drug was most used. The
discrepancy between no observed factual use of the in-
terventions in the field observation and a comparatively
higher self-reported use could have several reasons. The
field observation time was limited and may have missedcritical patient cases or physicians with a higher use
of the interventions. A Hawthorne effect cannot be
excluded, which could have resulted in lesser use of inter-
ventions than expected. There may be a discrepancy be-
tween intention to use and actual use, see below.
Regarding the second research question, results of the
questionnaire showed a moderate (paper-based interven-
tions) to rather high (computer-based interventions) degree
of acceptance respectively intention to use the medication
safety measures in future. Overall, the computer-based
interventions tend to be better accepted than the
paper-based interventions such as repeated training,
checklist and posters which corresponds to the higher
self-reported utilization of computer based interven-
tions. However, due to our small sample size these
differences are not significant. Zhang et al. [38],
Chismar and Wiley-Patton [35] and Yu et al. [37] -
who applied TAM2 - have identified perceived useful-
ness as the most important determinant of accept-
ance. This is in line with our results, although only
significant for computer-based interventions. As phy-
sicians were generally positive towards the usefulness
of the interventions, an important pre-condition to
promote improved medication safety is given.
Concerning the self-rated suitability for the ED,
computer-based interventions and the repeated medica-
tion safety training received the highest ranking and
therefore seem to be the best strategy in the eyes of ED
physicians. Paper-based checklists ranked second; post-
ers were judged less appropriate. An assessment of the
outcome of these interventions (e.g. reduction of adverse
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a more comprehensive picture of the overall suitability
and is planned for future research.
Related to the third research question - reasons for (non)
utilization and recommendations for improvement - field
observation results indicated that availability and time
pressure might be a cause. Clinical work in ED is charac-
terized by many unexpected events and time critical
processes. In addition, the physicians move frequently be-
tween patients. Hence, interventions must be compatible
to the time critical and mobile nature of work and must
provide physicians with drug information at all locations.
Posters, for example were not visible from all treatment
cubicles. The fact that limited availability at the point of
care impedes usage behavior was also reported by
Rahmner et al. [47]. In contrast to posters, checklists were
directly available but were rarely applied, because of physi-
cians’ habit of using the “Arzneimittel pocket” (a German
pocket drug reference). Free comments in the question-
naire indicated, that the checklist containing only a small
number of critical drugs may have been too specific. All
computer-based interventions required previous manual
documentation of all drugs into the electronic case sheet.
Field observation (and log data) confirmed lack of time to
perform this tedious task. This is similar to other studies,
which reported lack of time as important drawback for
physicians [48-50]. As an indicator for a missing fit to
workflow we observed the need for workarounds to docu-
ment half or quarter tablet regimens.
TAM2 scales showed consistently that medication safety
interventions – despite being judged useful and of reason-
able information quality – were assessed negatively re-
garding ease-of-use and compatibility to existing work
procedures. Similar to us, other studies reported, that
ease-of-use remains a main barrier for rejection [51,52]
and that “fit” into the clinical work environment is an
important factor for adopting innovations [48]. Free com-
ments in the questionnaire indicated a lack of promotion
and briefing for interventions, which we believe is an add-
itional reason for low utilization. Support for this conclu-
sion is offered by Avery et al. [51] and Patterson et al. [53],
who identified system training as significant factor con-
tributing to physicians’ use. In addition, Aydin and
Forsythe [54] found that physicians “must be comfortable
enough with the system to use it in patient’s presence”.
Wu et al. [43] have shown that training programs and
support will enhance physicians’ confidence and increase
perceptions of ease-of-use and usefulness.
From these results we derive several recommendations
for enhancing acceptance and usage of medication safety
interventions in ED, which are:
 to emphasize the potential benefits of such
interventions, to establish an automated drug documentation as a
prerequisite electronic medication safety
interventions. This could be realized with a transfer
of medication data from the future electronic health
insurance card,
 to signal feedback regarding the utilization of
medication safety interventions, e.g. in meetings and
training sessions and
 to give physicians more time to adapt to new ways
of working.
To what extent the findings of this study and its rec-
ommendations will actually lead to a higher level of
acceptance and more frequent utilization remains an in-
teresting question for a follow-up study.
Consolidating the results, our findings indicate a gap
between usage and intention to use: Paper-based and
computer-based interventions in general are accepted,
but physicians do not systematically use them. This is
consistent to other studies that demonstrated that al-
though physicians developed an intention to use IT, they
did not use it [55-57]. Among the reasons we identified
lack of access, missing briefing for the interventions,
inappropriate ease-of-use, missing compatibility to
existing workflows and lacking time for familiarization
(see research question 3). The TAM2 items for intention
to use refer to “if barriers would have been overcome”.
In our case, physicians are willing to apply the interven-
tions but refrain because of these barriers.
For computer-based intervention we found a positive
relationship between perceived usefulness (PU) respect-
ively compatibility (COM) and the intention to use the
interventions in future (PU – ITU, r = 0.960, p < 0.05;
COM – ITU, r = 0.917, p < 0.05). Therefore, addressing
these factors is important for reaching a high acceptance
of medication safety interventions. With 0.960 the PU –
ITU value is above those of Venkatesh and Davis [23],
Heselmans et al. [58] and Tung et al. [44] who measured
correlation coefficients between 0.44 and 0.73, but this
result must be considered cautiously in view of the small
sample size. In general, with many correlation coeffi-
cients being non-significant even in the range of 0.7 to
0.8, the sensitivity of our study to detect other, poten-
tially relevant correlations is admittedly low. Neverthe-
less, our results are comparable to TAM2 findings of
previous health IT research [35-38] and indicate the
applicability of TAM2 for a busy ED environment.
Implications for practice and research
We could demonstrate that TAM2 is a useful diagnostic
instrument to understand usage of medication safety
measures. Our results may help identifying strategies
and focusing tasks for enhancing acceptance. Implica-
tions for further research arise from the fact that the
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and therefore some of the items do not meet ED re-
quirements. To measure e.g. subjective norm as social
influence of the opinion of other physician colleagues
may not be meaningful in the ED context, because
sources of social influence may rather be department
heads or nursing staff. Although (modified) TAM2 com-
prises variables that are related to usage intention this
does not mean that these variables are all-embracing.
There may be other factors such as trust, accessibility,
visible management support, that could serve as barriers
to ED physician’s adoption. A challenge is to identify
and to test these alternative factors in order to develop a
further improved and more contextualized version of
TAM2.
Limitations of the study
The application oriented context of this study required
pragmatic solutions at various points. The study was
conducted in one ED only, where specific interventions
to improve medication safety had been implemented.
Use of the interventions and of electronic documenta-
tion was voluntary. Findings cannot be generalized to
other settings and other interventions without further
research. The field observation examined only a small
proportion of physicians working at the ED and a small
patient sample. Due to anonymization we could not test-
ify the real need for a medication check for each of those
patients. The questionnaire survey included 75 percent
of the candidates working permanently in the ED, but
not those physicians from other departments working
occasionally in night shifts and weekends in the ED. The
questionnaire sample was small rendering statistical
work-up difficult, thus the results must be interpreted
with caution. To detect relationships between TAM2
variables we used Pearson’s score which assumes met-
rical data. This is disputable from a statistical point of
view, but our approach makes the study comparable to
other TAM based research [45,58]. Further, participation
of nine of eligible 12 ED physicians in the TAM assess-
ment may indicate some volunteer bias. Due to the sample
size the TAM2 model assumptions could not be calcu-
lated, therefore additional research is indicated to deter-
mine the degree of influence of the different acceptance
factors on system utilization. We relied on the TAM2
variables and did not assess other potentially relevant
variables such as trust in the provided information, com-
puter self-efficacy, or the availability of organizational or
technical support. Ideally an acceptance study takes place
during system development and is repeated after rollout
of the (improved) system. In comparison, this study exam-
ined utilization and acceptance retrospectively with no
direct impact of its results to improve the implemented
medication safety interventions.What this study adds to knowledge
Although the TAM model has been applied across a
number of health contexts and technologies [26,27] only
few studies related to medication safety [15,59], CDSS
[46,58] or the ED context [60] could be identified. To
our knowledge, TAM2 has not been previously applied
in the ED area making this one of the first studies of its
kind. Also new is the extension of TAM2 with the fac-
tors “resistance to change” and “compatibility” which
allowed additional insight into ED physicians’ behavioral
intention and actual usage.
We could show that physicians preferred especially
the medication safety training and computer-assisted
safety checks. Computer-assisted interventions (infobutton,
CDSS and DIS) tend to be better accepted compared
to paper-based interventions, despite their still low
ease-of-use and workflow fit.
Conclusions
The aim of this study was to evaluate physicians’ use
and acceptance of different interventions in an ED and
to identify reasons why interventions are adopted or
rejected. We found it critical that, despite their positive
attitude, physicians reported use of interventions in only
ten percent of critical orders which correlates to our
observation results. Thus we recommend increased
attention to the main barriers identified in our study
which include insufficient access, insufficient briefing
for the use of interventions, insufficient compatibility to
workflow, lacking ease-of-use and lacking time for
familiarization. We encourage other EDs to assess medica-
tion safety interventions from a multi-factor perspective,
not only focusing on technical aspects, but also on change
management.
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